BioRestorative Therapies Inc (BRTX)

[I-Glow]

There is no Value in clinical trials - they are very expensive - Phase 2 and Phase 3 will cost at least $50 million and BRTX doesn't have access to Capital - then there is the cost of bringing the drug to market.

The percent of drugs that gain FDA approval is 10% or less.

Being in clinical trials doesn't add any value.

IG